Viewing nowCombinationEmpaganduo Tablets 12.5/500 mg (Empagliflozin, Metformin Hydrochloride)
Empagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Biopharmaceutical Co., Ltd.

MFDS item code 202302304 · Approved 2023.07.31 · Insurance code 657309120
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication helps manage blood sugar levels in adult patients with type 2 diabetes who have inadequate blood sugar control using Empagliflozin and Metformin together. It is more effective when combined with diet and exercise, especially in patients with cardiovascular diseases, and should be used cautiously considering its impact on cardiovascular events. This medication improves blood sugar control and aids in diabetes management.
The recommended dosage of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose when starting this medicine is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If a dose is missed, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dosage adjustment is necessary for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who have no other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered as this medicine is 1000 mg, given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients in Whom the Medicine Must Not Be Used, item 2)). Elderly patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication may cause severe lactic acidosis; therefore, it should not be used by patients with renal impairment, severe infections, dehydration, or acute cardiac conditions. Additionally, it is not recommended for type 1 diabetes patients or those with a history of lactic acidosis. Care should be taken as hypoglycemia may occur when used with insulin or sulfonylureas. This medication should be temporarily discontinued before and after tests involving iodinated contrast agents, and should only be resumed once renal function is confirmed normal. It is safest for pregnant or breastfeeding women not to take this medication. Elderly patients or those with renal impairment should have regular monitoring of renal function and dosage adjustments if needed. If dehydration or gastrointestinal disturbances occur during treatment, immediate consultation with a healthcare provider is necessary, and in cases of severe fluid loss, temporary cessation of medication may be needed. There is a risk of vitamin B12 deficiency, so monitoring serum vitamin B12 levels during prolonged use is advised. Hypoglycemia symptoms may appear, so do not skip meals and monitor blood sugar levels closely after vigorous exercise. This medication may increase the risk of genital and urinary tract infections, so prompt treatment is required if related symptoms occur. If pain, swelling, or redness around the genital area occurs during medication, inform the healthcare provider immediately. In cases where food intake is not possible for a long period due to surgery or significant illness, temporary discontinuation of this medication may be necessary. In case of overdose, treatments like dialysis may be required, making adherence to the prescribed dosage important. It is advised to avoid alcohol while taking this medication, and consult with healthcare providers if taking other medications that may interact.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. It is important to maintain storage temperatures between 1 degree and 30 degrees Celsius at room temperature to ensure prolonged safety and effectiveness.
Biconvex oval film-coated tablets with a light brownish purple color
60 tablets/box [10 tablets/PTP x 6], 10 tablets/box [10 tablets/PTP x 1], 30 tablets/bottle, 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Biopharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.